2011
DOI: 10.1016/j.biomaterials.2010.10.009
|View full text |Cite
|
Sign up to set email alerts
|

Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
135
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 142 publications
(135 citation statements)
references
References 42 publications
(52 reference statements)
0
135
0
Order By: Relevance
“…[103][104][105][106] For instance, Annabi et al developed a two-stage solvent-free dense gas technique to produce porous 3D structures of natural/synthetic polymeric composites. 107 In the first stage, a gas-foaming/saltleaching process was used to create large pores with an average pore size of 540 -21 mm in a PCL matrix.…”
Section: -102mentioning
confidence: 99%
“…[103][104][105][106] For instance, Annabi et al developed a two-stage solvent-free dense gas technique to produce porous 3D structures of natural/synthetic polymeric composites. 107 In the first stage, a gas-foaming/saltleaching process was used to create large pores with an average pore size of 540 -21 mm in a PCL matrix.…”
Section: -102mentioning
confidence: 99%
“…For this reason, recent research has focused on the role of biomaterials or the roles played by hypoxia and chondrogenic factors to induce the redifferentiation of dedifferentiated chondrocytes. 19,33,34 However, a few cellular therapy approaches to inhibit type I collagen have shown great efficiency. We previously showed that dedifferentiated chondrocytes cultured in type I collagen sponges under hypoxia (3% O 2 ) express more type II collagen and aggrecan than in normoxia (21% O 2 ) and that BMP-2 favors this process.…”
Section: Discussionmentioning
confidence: 99%
“…9 Therefore, therapeutic interventions must either aim to prevent the loss of this layer at early disease stages, or to regenerate this layer in later disease stages. Growing attention has been focused on such regeneration of stratified repair tissue, [10][11][12] however, cell source remains a major challenge for zonal cartilage engineering efforts. Bone marrow-derived mesenchymal stem cells (MSCs) are potential treatment populations for articular cartilage defects.…”
mentioning
confidence: 99%
“…Typically, MSCs are cultured in a micromass or hydrogel and delivered chondrogenic media supplemented with transforming-growth factor bs (TGF-bs) and dexamethasone to induce chondrogenesis. Methods for inducing zone-specific chondryctes are yet to be established, but growth factor delivery 13 and cues from the scaffold environment 11 show potential for guiding progenitor populations to zone-specific cells.…”
mentioning
confidence: 99%